Q. J. Zhang

Interleukin 10 pretreatment protects target cells from tumor- and allo- specific cytotoxic T cells and downregulates HLA class I expression

M. Matsuda, R. Kiessling, M. Masucci, 1994, The Journal of experimental medicine.

HLA-A11-mediated protection from NK cell-mediated lysis: role of HLA-A11-presented peptides.

M. Masucci, R. Gavioli, Q. J. Zhang, 1996, Human immunology.

Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.

G. Klein, M. Masucci, P. Trivedi, 1993, Molecular immunology.

Solvent exposed side chains of peptides bound to HLA A*1101 have similar effects on the reactivity of alloantibodies and specific TCR.

V. Levitsky, M. Masucci, Q. J. Zhang, 1996, International immunology.

The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4

V. Levitsky, M. Masucci, J. Levitskaya, 1996, The Journal of experimental medicine.

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.

M. Masucci, M. Rowe, R. Gavioli, 1993, Science.

An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.

G. Klein, M. Masucci, R. Gavioli, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes.

M. Masucci, R. Gavioli, R. Guerrini, 1995, Biochemical and biophysical research communications.

Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes.

V. Levitsky, M. Masucci, J. Levitskaya, 1997, Journal of immunology.

Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma.

G. Winberg, G. Klein, J. Minárovits, 1995, Oncogene.